Enhancing the action of incretin hormones: a new whey forward?
Drucker
Daniel J
DJ
Department of Medicine and the Banting and Best Diabetes Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada M5G 2C4.
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000628:therapy; D005749:Gastric Inhibitory Polypeptide / Q000737:chemistry; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000737:chemistry; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D051379:Mice; D008894:Milk Proteins / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry; D051381:Rats; D000067816:Whey Proteins
D005768:Gastrointestinal Hormones; D006728:Hormones; D007328:Insulin; D008894:Milk Proteins; D010455:Peptides; D000067816:Whey Proteins; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1